Phase II, open-label, randomized trial of the MEK1/2 inhibitor selumetinib as monotherapy versus temozolomide in patients with advanced melanoma. Kirkwood JM, Bastholt L, Robert C, Sosman J, Larkin J, Hersey P, Middleton M, Cantarini M, Zazulina V, Kemsley K, Dummer R (2012) Clin Cancer Res 18: 555-67 Impact of generic substitution decision support on electronic prescribing behavior. Stenner SP, Chen Q, Johnson KB (2010) J Am Med Inform Assoc 17: 681-8 Comparative Effectiveness of Insulin versus Combination Sulfonylurea and Insulin: a Cohort Study of Veterans with Type 2 Diabetes. Min JY, Griffin MR, Hung AM, Grijalva CG, Greevy RA, Liu X, Elasy T, Roumie CL (2016) J Gen Intern Med 31: 638-46 Patient satisfaction in postmenopausal women treated with a weekly bisphosphonate transitioned to once-monthly ibandronate. Bonnick SL, Silverman S, Tanner SB, Martens M, Bachmann G, Kohles JD, Civitelli R (2009) J Womens Health (Larchmt) 18: 935-43
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.